3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Conditions
Tuberous Sclerosis
3
Seizures
3
Sturge-Weber Syndrome
2
Nausea
2
Vomiting
1
Parasomnias
1
Pain
1
Neoplasms
1
Marijuana Abuse
1
Dysgeusia
1
Drug Resistant Epilepsy
1
Cognitive Dysfunction
1
Chemotherapy-Induced Peripheral Neuropathy
1
Cancer Pain
1
Cachexia
1
Breast Neoplasms
1
Behavior
1
Arthralgia
1
Appetitive Behavior
1
Anxiety Disorders
1
Interventions
Surveys and Questionnaires
3
Melatonin
3
Yoga
2
Exercise
2
Control Groups
2
nabiximols
1
Sugars
1
Modafinil
1
Minocycline
1
Mindfulness
1
Massage
1
Exercise Movement Techniques
1
Dronabinol
1
Cannabidiol
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Completed
×
Parasomnias
×
Cannabidiol
×
Clear all
NCT03948074
2025-09-10
CAFCARS
British Columbia Cancer Agency
Phase 2
Completed
91 enrolled